TMDX Q3 2024 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena

TMDXTransMedics Group, Inc.

$5B

Q3 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$109M+63.7% YoY

Gross Profit

$61M55.9% margin

Operating Income

$4M3.6% margin

Net Income

$4M3.9% margin

EPS (Diluted)

$0.12

QoQ Revenue Growth

-4.9%

Cash Flow

Operating Cash Flow

$7M

Free Cash Flow

-$41M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$786M

Total Liabilities

$576M

Stockholders' Equity

$210M

Cash & Equivalents

$330M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$109M	$66M	+63.7%
Gross Profit	$61M	$41M	+49.6%
Operating Income	$4M	-$28M	+113.8%
Net Income	$4M	-$25M	+116.6%

Revenue Segments

Product

$66M61%

Service

$43M39%